🇺🇸 FDA
Patent

US 10808247

Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach

granted A61KA61K2300/00A61K31/36

Quick answer

US patent 10808247 (Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach) held by Phio Pharmaceuticals Corp. expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phio Pharmaceuticals Corp.
Grant date
Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2300/00, A61K31/36, A61K31/444, A61K31/713